Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.
Kelly K, Crowley JJ, Bunn PA Jr, Hazuka MB, Beasley K, Upchurch C, Weiss GR, Hicks WJ, Gandara DR, Rivkin S, et al. Kelly K, et al. Among authors: beasley k. J Clin Oncol. 1995 Dec;13(12):2924-30. doi: 10.1200/JCO.1995.13.12.2924. J Clin Oncol. 1995. PMID: 8523056 Clinical Trial.
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
Bunn PA Jr, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR, et al. Bunn PA Jr, et al. Among authors: beasley k. J Clin Oncol. 1995 Jul;13(7):1632-41. doi: 10.1200/JCO.1995.13.7.1632. J Clin Oncol. 1995. PMID: 7602352 Clinical Trial.
Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.
Habib AA, Benatar M, Vu T, Meisel A, Attarian S, Katsuno M, Liao S, Beasley KN, Howard JF Jr. Habib AA, et al. Among authors: beasley kn. Eur J Neurol. 2024 Dec;31(12):e16490. doi: 10.1111/ene.16490. Epub 2024 Oct 7. Eur J Neurol. 2024. PMID: 39373062 Free PMC article. Clinical Trial.
Nuclear receptor corepressor 1 levels differentially impact the intracellular dynamics of mutant thyroid hormone receptors associated with resistance to thyroid hormone syndrome.
Simsek YK, Tofil HP, Rosenthal MI, Evans RM, Danielski CL, Beasley KE, Alsayed H, Shapira ME, Strauss RI, Wang M, Roggero VR, Allison LA. Simsek YK, et al. Among authors: beasley ke. Mol Cell Endocrinol. 2024 Dec 1;594:112373. doi: 10.1016/j.mce.2024.112373. Epub 2024 Sep 17. Mol Cell Endocrinol. 2024. PMID: 39299378 Free article.
Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage.
Pradilla G, Ratcliff JJ, Hall AJ, Saville BR, Allen JW, Paulon G, McGlothlin A, Lewis RJ, Fitzgerald M, Caveney AF, Li XT, Bain M, Gomes J, Jankowitz B, Zenonos G, Molyneaux BJ, Davies J, Siddiqui A, Chicoine MR, Keyrouz SG, Grossberg JA, Shah MV, Singh R, Bohnstedt BN, Frankel M, Wright DW, Barrow DL; ENRICH trial investigators; ENRICH Trial Investigators. Pradilla G, et al. N Engl J Med. 2024 Apr 11;390(14):1277-1289. doi: 10.1056/NEJMoa2308440. N Engl J Med. 2024. PMID: 38598795 Clinical Trial.
The role of stroke care infrastructure on the effectiveness of a hub-and-spoke telestroke model in South Carolina.
Srinivasan M, Scott A, Soo J, Sreedhara M, Popat S, Beasley KL, Jackson TN, Abbas A, Keaton WA, Holmstedt C, Harvey J, Kruis R, McLeod S, Ahn R. Srinivasan M, et al. Among authors: beasley kl. J Stroke Cerebrovasc Dis. 2024 Jun;33(6):107702. doi: 10.1016/j.jstrokecerebrovasdis.2024.107702. Epub 2024 Mar 29. J Stroke Cerebrovasc Dis. 2024. PMID: 38556068
120 results